Search

everythinglearnresearchcommunity

for

Search:↓

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

More effective treatments are needed for severe alopecia areata.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Platelet-Rich Plasma (PRP) may be a safe and effective treatment for hair loss caused by Alopecia Areata.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

COVID-19 reinfection may trigger alopecia areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Alopecia causes patchy hair loss and can be diagnosed with new techniques; treatments like strong creams and contact immunotherapy can help.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Early-stage Alopecia Areata was effectively treated in less than six months.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

The patient's hair loss is most likely due to diffuse alopecia areata.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Tempol is safe and may prevent hair loss from brain radiotherapy.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.